Table. 1 Main characteristics of studies included in the meta-analysis
From: Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis
First author, Publication year | Case nationality | Male (%) | Domi nant ethnicity | Main pathological type | Disease type | Detec ted sample | Outco me measures | Sourc e of HR | Maxi mum months of follow-up | Assay method |
|---|---|---|---|---|---|---|---|---|---|---|
Nakamura et al., 2019 | Japan | 0.79 | Asian | Urothelial carcinoma | Bladder cancer | Tissue | PFS | Reported | 95 | IHC |
Tzeng et al., 2016 | China | N/A | Asian | Squamous cell carcinoma | Esophagus cancer | Tissue | PFS | SC | 228 | IHC |
Rouanne et al., 2016 | France | 0.67 | Caucasian | Adenocarcinoma | Lung cancer | Serum | OS/DFS | Reported | 34 | ELISA |
Teraoku et al., 2016 | Japan | 0.35 | Asian | Adenocarcinoma | Colon cancer | Tissue | OS/DFS | SC | 168 | IHC |
Campone et al., 2015 | France | N/A | Caucasian | Adenocarcinoma | Breast cancer | Tissue | OS | SC | 279 | IHC |
Eto et al., 2015 | Japan | 0.8 | Asian | Adenocarcinoma | Gastric cancer | Tissue | OS | SC | 60 | IHC |
Yao et al., 2014 | China | 0.68 | Asian | Non-Small Cell Lung Cancer | Lung cancer | Tissue | OS/DFS | Reported | 60 | ELISA |
Sharma et al., 2013 | India | 92.5 | Asian | Hepatocellular Carcinoma | Liver cancer | Tissue | OS | Reported | 33 | PCR |
Pectasides et al., 2012 | Greece | 0 | Caucasian | Adenocarcinoma | Breast cancer | Tissue | OS/PFS | Reported | 45 | PCR |
Nakao et al., 2011 | Japan | 0.8 | Asian | Adenocarcinoma | Gastric cancer | Tissue | OS | SC | 50 | IHC |
Zhou et al., 2009 | China | 0.73 | Asian | Squamous cell carcinoma | esophagus cancer | Tissue | OS | Reported | 50 | IHC |
Randall et al., 2009 | USA | N/A | Caucasian | Squamous cell carcinoma | Cervical cancer | Tissue | OS/PFS | Reported | 184.8 | IHC |
Yang et al., 2009 | China | 0.51 | Asian | mucoepidermoid carcinoma | Oral cancer | Tissue | DFS | SC | 60 | IHC |
Secord et al., 2007 | USA | 0 | Caucasian | Epithelial cancer | Ovarian cancer | Tissue | OS/PFS | Reported | 110 | Immunoblot analysis |
Wada et al., 2006 | Japan | 0.75 | Asian | Hepatocellular Carcinoma | Liver cancer | Tissue | DFS | SC | 60 | IHC |
Sutton et al., 2005 | UK | 0.67 | Caucasian | Adenocarcinoma | Colon cancer | Tissue | OS | Reported | 60 | Dextran polymer conjugate wwo-step visualization system |
Fontana et al., 2005 | France | N/A | Caucasian | Adenocarcinoma | Breast cancer | Tissue | PFS | SC | 160 | IHC |
Poon et al., 2004 | China | 0.82 | Asian | Hepatocellular Carcinoma | Liver cancer | Tissue | OS | SC | 38 | IHC |
Aishima et al., 2002 | Japan | N/A | Asian | Intrahepatic Cholangiocarcinoma | Liver cancer | Tissue | OS | SC | 120 | IHC |
Maeda et al., 2001 | Japan | 0.63 | Asian | Adenocarcinoma | Colon cancer | Tissue | DFS | Reported | 60 | IHC |
Straume et al., 2001 | Norway | N/A | Caucasian | Melanomas | Skin cancer | Tissue | OS | SC | 210 | IHC |
Kodama et al., 2001 | Japan | N/A | Asian | Squamous cell carcinoma | Cervical cancer | Tissue | DFS | Reported | 59 | PCR |
You et al., 2000 | China | 0.57 | Asian | Squamous cell carcinoma | Lung cancer | Tissue | OS | SC | 120 | IHC |
Yao et al., 2000 | Japan | N/A | Asian | Squamous cell carcinoma | Oral cancer | Tissue | OS | SC | 60 | IHC |